Lung transplantation continues to evolve as a therapeutic option for p
atients with end-stage lung disease. Bilateral sequential single lung
transplantation (BSSLTx) is a recent addition to the lung transplant s
urgeon's armamentarium that incorporates the benefits of single lung t
ransplantation in patients who require double lung replacement while a
voiding the morbidity inherent in the en bloc double lung transplant p
rocedure. Between November 1992 and October 1993, 17 recipients underw
ent 18 bilateral BSSLTx procedures for a variety of indications. In 53
% of patients, the procedure was completed without the requirement for
cardiopulmonary bypass. Telescoping of the bronchial anastomosis has
proved satisfactory. Induction cytolytic therapy has not been utilized
. Patients received methyl prednisolone from day 1 and as maintenance
prednisolone therapy. Actuarial 1-year survival is 87%; 12 of the 15 s
urvivors are in Functional Class I. BSSLTx is an evolving transplant o
ption for patients who require double lung replacement. Definitive cli
nical diffusion of the procedure will depend upon intermediate and lon
g-term outcomes for specific recipient pathologies.